Skip to content

Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits

Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04024007
Enrollment
100
Registered
2019-07-18
Start date
2019-09-01
Completion date
2023-12-01
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis

Brief summary

Citrate anticoagulation is becoming the gold standard in dialysis in intensive care units. It is now accepted that citrate prolongs the life of filters with a lower risk of bleeding. However, the management of citrate is complex. Optimization is based on citrate flow, blood flow and the amount of calcium reinjected. Frequently the citrate level is sub-dosed.Currently, the fraction of excretion of citrate by the hemodialysis machine is unknown. Knowing this information would allow, if it is important enough, to add an additional parameter of citrate management by adapting the level of dialysis. The determination of citrate in an extracorporeal circulation circuit has already been performed and has been validated in the literature. We propose to perform the assay on subjects with the same starting parameters, in order to deduce the clearance of citrate.

Interventions

DIAGNOSTIC_TESTCitrate dosage

Patients are dialysed according to the standard of care. Biological variables are measured in pre-filter, post-filter and dialysate 30 minutes after the dialysis is initiated.

Sponsors

Dr David DE BELS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Intensive care dialysis patients (Continuous Venous Hemofiltration with citrate).

Exclusion criteria

\- None

Design outcomes

Primary

MeasureTime frameDescription
Citrate concentration - pre-filter30 minutes after the start of dialysisCitrate concentration in a blood sample taken before the dialysis filter
Citrate concentration - post-filter30 minutes after the start of dialysisCitrate concentration in a blood sample taken after the dialysis filter
Citrate concentration - dialysate30 minutes after the start of dialysisCitrate concentration in a blood sample taken in the dialysate

Secondary

MeasureTime frameDescription
AgeBaselineAge
Apache II scoreBaselineThe APACHE II score is calculated at the beginning of the intensive care unit admission to help determine the patient's mortality risk for the admission. An integer score from 0 to 71 is computed based on several measurements; higher scores correspond to more severe disease and a higher risk of death.
SOFA (Sequential Organ Failure Assessment) scoreBaselineThe Sequential Organ Failure Assessment score (SOFA score), is used in intensive care units to determine and track the status of a patient with organ failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. Higher scores mean a higher risk of mortality.
Glomerular filtration rate (GFR)BaselineGlomerular filtration rate
Creatinin levelBaselineCreatinin level
DiuresisBaselineVolume of urinary secretion in the last 12 hours
KDIGO classificationBaselineThe KDIGO classification defines 3 stages of increasing severity for acute kidney injuries.
Na (sodium) concentration -pre-filter30 minutes after the start of dialysisNa (sodium) concentration in a blood sample taken before the dialysis filter
Na (sodium) concentration -post-filter30 minutes after the start of dialysisNa (sodium) concentration in a blood sample taken after the dialysis filter
Cl (chlorine) concentration - pre-filter30 minutes after the start of dialysisCl (chlorine) concentration in a blood sample taken before the dialysis filter
Cl (chlorine) concentration -post-filter30 minutes after the start of dialysisCl (chlorine) concentration in a blood sample taken after the dialysis filter
K (potassium) concentration - pre-filter30 minutes after the start of dialysisK (potassium) concentration in a blood sample taken before the dialysis filter
K (potassium) concentration - post-filter30 minutes after the start of dialysisK (potassium) concentration in a blood sample taken after the dialysis filter
Total Ca (calcium) concentration -pre-filter30 minutes after the start of dialysisCa (calcium) concentration in a blood sample taken before the dialysis filter
Total Ca (calcium) concentration -post-filter30 minutes after the start of dialysisCa (calcium) concentration in a blood sample taken after the dialysis filter
Total Ca (calcium) concentration -dialysate30 minutes after the start of dialysisCa (calcium) concentration in the dialysate
Ionized calcium (Ca2+) concentration -pre-filter30 minutes after the start of dialysisCa (calcium) concentration in a blood sample taken before the dialysis filter
Ionized calcium (Ca2+) concentration -post-filter30 minutes after the start of dialysisCa (calcium) concentration in a blood sample taken after the dialysis filter
Ionized calcium (Ca2+) concentration -dialysate30 minutes after the start of dialysisCa (calcium) concentration in the dialysate
Mg (magnesium) concentration - pre-filter30 minutes after the start of dialysisMg (magnesium) concentration in a blood sample taken before the dialysis filter
Mg (magnesium) concentration - post-filter30 minutes after the start of dialysisMg (magnesium) concentration in a blood sample taken after the dialysis filter
PO4 (phosphate) concentration - pre-filter30 minutes after the start of dialysisPO4 (phosphate) concentration in a blood sample taken before the dialysis filter
PO4 (phosphate) concentration - post-filter30 minutes after the start of dialysisPO4 (phosphate) concentration in a blood sample taken after the dialysis filter
Lactate concentration - pre-filter30 minutes after the start of dialysisLactate blood concentration in a blood sample taken before the dialysis filter
Lactate concentration - post-filter30 minutes after the start of dialysisLactate blood concentration in a blood sample taken after the dialysis filter
Albumin concentration -pre-filter30 minutes after the start of dialysisAlbumin concentration in a blood sample taken before the dialysis filter
Albumin concentration -post-filter30 minutes after the start of dialysisAlbumin concentration in a blood sample taken after the dialysis filter
pH - pre-filter30 minutes after the start of dialysispH of a blood sample taken before the dialysis filter
pH - post-filter30 minutes after the start of dialysispH of a blood sample taken after the dialysis filter
Total C-reactive protein (CRP) -pre-filter30 minutes after the start of dialysisTotal CRP concentration in a blood sample taken before the dialysis filter
Total C-reactive protein (CRP) -post-filter30 minutes after the start of dialysisTotal CRP concentration in a blood sample taken after the dialysis filter
Total C-reactive protein (CRP) -dialysate30 minutes after the start of dialysisTotal CRP concentration in a blood sample taken in the dialysate
WeightBaselineWeight
Monomeric C-reactive protein (CRP) -post-filter30 minutes after the start of dialysisMonomeric CRP concentration in a blood sample taken after the dialysis filter
Monomeric C-reactive protein (CRP) -dialysate30 minutes after the start of dialysisMonomeric CRP concentration in a blood sample taken in the dialysate
Monomeric C-reactive protein (CRP) -pre-filter30 minutes after the start of dialysisMonomeric CRP concentration in a blood sample taken before the dialysis filter
HeightBaselineHeight
SexBaselineSex

Countries

Belgium

Contacts

Primary ContactSébastien Redant, MD
Sebastien.REDANT@chu-brugmann.be3224773100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026